May 11, 2026

Becton, Dickinson (BDX) Stock Analysis: Uncovering a 22.66% Upside in the Healthcare Giant

Becton, Dickinson and Company (BDX), a stalwart in the healthcare sector, stands out as a pivotal player in the medical instruments and supplies industry. With a robust market capitalization of..

Centene Corporation (CNC) Stock Analysis: Navigating Revenue Growth and Market Positioning

As the healthcare industry continues to evolve, Centene Corporation (NYSE: CNC) stands out as a formidable player, particularly in the realm of managed care services. With a market capitalization of..

Ascendis Pharma A/S (ASND) Stock Report: Analyst Ratings Suggest 24% Upside Potential

Ascendis Pharma A/S (NASDAQ: ASND), a burgeoning entity in the biotechnology sector, has captured investor attention with its promising pipeline of therapies aimed at unmet medical needs. Based in Hellerup,..

Gilead Sciences (GILD) Stock Analysis: A 20% Upside Potential Amid Robust Growth in Healthcare

Gilead Sciences, Inc. (NASDAQ: GILD), a prominent player in the healthcare sector, presents a compelling opportunity for investors seeking exposure to the biopharmaceutical industry. With a market capitalization of $163.06..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Unpacking a 67.83% Potential Upside for Biotech Investors

Summit Therapeutics Inc. (NASDAQ: SMMT), a prominent player in the biotechnology sector, is capturing the interest of investors with its innovative approach in the healthcare industry. Headquartered in Miami, Florida,..

Illumina, Inc. (ILMN) Stock Analysis: Navigating the Genomic Frontier with Strong Revenue Growth and Strategic Partnerships

Illumina, Inc. (ILMN), a cornerstone in the healthcare sector, continues to captivate investors with its robust position in the diagnostics and research industry. With a market capitalization of $21.47 billion,..

The Ensign Group, Inc. (ENSG) Stock Analysis: Strong Growth with 28.55% Potential Upside

The Ensign Group, Inc. (NASDAQ: ENSG) is a standout player in the healthcare sector, with a focus on medical care facilities across the United States. With a robust market cap..

CVS Health Corporation (CVS) Stock Analysis: Navigating 10.69% Potential Upside in Healthcare Plans

CVS Health Corporation (NYSE: CVS), a titan in the healthcare sector, presents a compelling opportunity for investors seeking exposure to the healthcare plans industry. With a substantial market capitalization of..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Growth Potential and Strategic Insights Amid Market Fluctuations

Medpace Holdings, Inc. (NASDAQ: MEDP) has positioned itself as a formidable player within the Healthcare sector, specifically in the Diagnostics & Research industry. The company’s expansive footprint across North America,..

Halozyme Therapeutics (HALO) Stock Analysis: Exploring a Promising 33.78% Upside Potential

Halozyme Therapeutics, Inc. (NASDAQ: HALO) is catching the eye of investors with a robust upside potential of 33.78%, according to recent analyst ratings. Specializing in biotechnology, the company is a..

AptarGroup, Inc. (ATR) Stock Analysis: Evaluating a 34.96% Potential Upside in the Healthcare Sector

AptarGroup, Inc. (NYSE: ATR) is a formidable player in the medical instruments and supplies industry, operating primarily within the healthcare sector. With its headquarters in Crystal Lake, Illinois, AptarGroup has..

Encompass Health Corporation (EHC) Stock Analysis: Unpacking a 32.55% Potential Upside

Investors in Encompass Health Corporation (NYSE: EHC) might find themselves at an intriguing crossroads as they consider the potential trajectory of this healthcare giant. Specializing in inpatient rehabilitation services, Encompass..

Waters Corporation (WAT) Investor Outlook: Navigating a 11.88% Potential Upside in the Diagnostics & Research Space

Waters Corporation (NYSE: WAT), a pivotal player in the healthcare sector, specifically within the diagnostics and research industry, offers intriguing prospects for individual investors. With a robust market capitalization of..

Agilent Technologies, Inc. (A) Stock Analysis: Exploring a Potential 38.98% Upside for Savvy Investors

Agilent Technologies, Inc. (NYSE: A) stands as a formidable player in the healthcare sector, prominently situated in the diagnostics and research industry. With a market capitalization of $32.67 billion, Agilent..

Bio-Techne Corp (TECH) Stock Analysis: Exploring a 29.52% Potential Upside Amidst Market Volatility

Bio-Techne Corp (NASDAQ: TECH), a prominent player in the healthcare sector’s biotechnology industry, offers a compelling investment opportunity with a potential upside of 29.52%. With a market capitalization of $7.57..

Exact Sciences Corporation (EXAS): Investor Outlook on This Healthcare Innovator’s 23.1% Revenue Growth

Exact Sciences Corporation (NASDAQ: EXAS), a leader in the healthcare sector, is gaining traction among investors for its innovative contributions to cancer diagnostics and research. Headquartered in Madison, Wisconsin, the..

BeOne Medicines Ltd. (ONC) Stock Analysis: A 31.77% Upside Potential Powers Investor Optimism

For investors keen on the biotechnology sector, BeOne Medicines Ltd. (ONC) represents a compelling opportunity with significant upside potential. Based in Basel, Switzerland, this oncology-focused biotech firm boasts a robust..

DexCom, Inc. (DXCM) Stock Analysis: 37.83% Potential Upside Captivates Investors

DexCom, Inc. (DXCM) stands as a prominent player in the healthcare sector, specializing in the innovative realm of medical devices. This San Diego-based company has carved out a niche in..

Corcept Therapeutics (CORT) Stock Analysis: Unveiling a 40% Potential Upside in the Biotech Sector

Corcept Therapeutics Incorporated (NASDAQ: CORT), a leading biopharmaceutical company, is capturing the attention of investors with its significant potential upside. With a market capitalization of $5.61 billion, this biotechnology firm..

Cencora, Inc. (COR) Stock Analysis: A 36.74% Potential Upside in the Healthcare Sector

Cencora, Inc. (COR), with a robust market capitalization of $50.8 billion, stands as a formidable player in the healthcare sector, specifically in medical distribution. This Conshohocken, Pennsylvania-based company, formerly known..

Search

Funds

May 11, 2026

Search

Funds

May 11, 2026

FTSE 100

Funds